General InformationRetro Biosciences is a California-based longevity biotech company founded in 2022 with 51-200 employees focused on cellular reprogramming and rejuvenation technologies.
Funding & FinancialsThe company has raised over $200 million in funding including a Series B round led by major investors in the longevity space.
Leadership & TeamFounded by a team of experienced biotech and longevity researchers; CEO and leadership background rooted in cellular biology and aging research.
Recent ActivityRecent focus on advancing clinical programs for cellular reprogramming therapies and building out research collaborations in the longevity sector.